BioSpace News Archive

BioMarin Pharmaceutical Inc. announced that the U.S. Food and Drug Administration has accepted the New Drug Application for vosoritide, an investigational, once daily injection analog of C-type Natriuretic Peptide for children with achondroplasia, the most common form of disproportionate short stature in humans.

The sites at the first two local health districts in NSW Health Care are now live with international medical imaging IT and cybersecurity company Sectra’s radiology imaging solution.

JW Therapeutics, a leading clinical stage cell therapy company in China that focuses on developing, manufacturing and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors, celebrates the initial public offering on the Main Board of the Stock Exchange of Hong Kong Limited.

STERIS plc announced financial results for its fiscal 2021 second quarter ended September 30, 2020.

Satsuma Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, announced that management will participate in the following conferences in the month of November.

Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted, first-in-class therapies for serious rare and ultra-rare diseases, today announced that data from its Hepatitis Delta Virus (HDV) programs are featured in three abstracts accepted for presentation during The Liver Meeting Digital Experience™ (TLMdX).

Forte Biosciences, Inc., a clinical-stage biopharmaceutical company, announced that it will release third quarter 2020 results after the market close on November 9, 2020 and will host a conference call at 4:30 pm ET to discuss third quarter 2020 results and to provide a general business update.

ImmunoGen, Inc. announced that on October 30, 2020 the compensation committee of the Company’s Board of Directors granted a non-qualified stock option award to purchase an aggregate of 21,500 shares of its common stock to a new employee under the ImmunoGen, Inc.

3D-printed anatomical models replicate biomechanics of human anatomy to help improve training, transform surgical planning and bring new medical innovations to market faster

Helius Medical Technologies, Inc., a neurotech company focused on neurological wellness, announced that third quarter of fiscal year 2020 financial results will be released after the market closes on Thursday, November 12th.